A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
Status:
Terminated
Trial end date:
2015-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the safety of six cycles of cenersen treatment and to
begin to test the hypothesis that intermittent administration of cenersen may lead to a
reduced dependence on transfusion.
Phase:
Phase 1
Details
Lead Sponsor:
Eleos, Inc.
Collaborator:
H. Lee Moffitt Cancer Center and Research Institute